Comparison between Remus Pharmaceuticals IPO and Spectrum Talent Management IPO.
Remus Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Spectrum Talent Management IPO is a SME Bookbuilding proposed to list at NSE SME.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Sarthi Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Remus Pharmaceuticals IPO is up to ₹45.29 Cr whereas the issue size of the Spectrum Talent Management IPO is up to ₹99.88 Cr. The final issue price of Remus Pharmaceuticals IPO is ₹1,229.00 per share and of Spectrum Talent Management IPO is ₹173.00 per share.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,150.00 per share | ₹169.00 per share |
| Issue Price (Upper) | ₹1,229.00 per share | ₹173.00 per share |
| Issue Price (Final) | ₹1,229.00 per share | ₹173.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 100 shares | 800 shares |
| Fresh Issue Size | 3,68,500 shares | 48,81,600 shares |
| Fresh Issue Size (Amount) | up to ₹45.29 Cr | up to ₹84.45 Cr |
| OFS Issue Size | 0 shares | 8,92,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.43 Cr |
| Issue Size Total | 3,68,500 shares | 57,73,600 shares |
| Issue Size Total (Amount) | up to ₹45.29 Cr | up to ₹99.88 Cr |
Remus Pharmaceuticals IPO opens on May 17, 2023, while Spectrum Talent Management IPO opens on Jun 09, 2023. The closing date of Remus Pharmaceuticals IPO and Spectrum Talent Management IPO is May 19, 2023, and Jun 14, 2023, respectively.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |
|---|---|---|
| Anchor Bid Date | May 16, 2023 | |
| Issue Open | May 17, 2023 | Jun 09, 2023 |
| Issue Close | May 19, 2023 | Jun 14, 2023 |
| Basis Of Allotment (Tentative) | May 24, 2023 | Jun 19, 2023 |
| Initiation of Refunds (Tentative) | May 25, 2023 | Jun 20, 2023 |
| Credit of Share (Tentative) | May 26, 2023 | Jun 21, 2023 |
| Listing date (Tentative) | May 29, 2023 | Jun 22, 2023 |
| Anchor Lockin End date 1 | Jun 23, 2023 | |
| Anchor Lockin End date 2 | Aug 22, 2023 |
Remus Pharmaceuticals IPO P/E ratio is 21.09, as compared to Spectrum Talent Management IPO P/E ratio of 15.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.82 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.37 | 72.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.09 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹181.03 Cr. | ₹89.71 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 71.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 69.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.86 | ₹10.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 52.64 | 42.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Remus Pharmaceuticals IPO Retail Individual Investors (RII) are offered 1,29,000 shares while in Spectrum Talent Management IPO retail investors are offered 1,29,000 shares. Qualified Institutional Buyers (QIB) are offered 73,700 shares in Remus Pharmaceuticals IPO and 5,76,000 shares in Spectrum Talent Management IPO.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,10,500 shares | |
| Market Maker Reservation | 19,500 shares | 3,04,000 shares |
| QIB | 73,700 shares | 5,76,000 shares |
| NII | 55,300 shares | 25,98,400 shares |
| RII | 1,29,000 shares | 25,99,200 shares |
| Employee | ||
| Others | ||
| Total | 3,68,500 shares | 57,73,600 shares |
Remus Pharmaceuticals IPO subscribed 57.21x in total, whereas Spectrum Talent Management IPO subscribed 12.27x.
| Remus Pharmaceuticals IPO | Spectrum Talent Management IPO | |
|---|---|---|
| QIB (times) | 10.75x | 11.21x |
| NII (times) | 229.31x | 11.68x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.81x | 13.10x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 57.21x | 12.27x |
